Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$430K Sell
5,856
-579
-9% -$37.1K 0.86% 45
2023
Q3
$401K Sell
6,435
-1,163
-15% -$78.2K 0.84% 50
2023
Q2
$562K Sell
7,598
-702
-8% -$53.5K 0.87% 44
2023
Q1
$654K Sell
8,300
-847
-9% -$61.1K 0.96% 34
2022
Q4
$625K Sell
9,147
-2,400
-21% -$152K 0.8% 58
2022
Q3
$613K Sell
11,547
-1,856
-14% -$111K 0.6% 76
2022
Q2
$841K Sell
13,403
-3,482
-21% -$213K 0.77% 55
2022
Q1
$1.09M Buy
16,885
+575
+4% +$39.3K 0.59% 71
2021
Q4
$1.37M Buy
16,310
+1,243
+8% +$99.6K 0.48% 75
2021
Q3
$1.18M Buy
+15,067
New +$1.25M 0.39% 92

Other funds holding BRKR

AtonRa Partners's BRKR Position: Q4 2023 in Review

AtonRa Partners reduced its Bruker (BRKR) stake by 9% in Q4 2023, selling an estimated $37.1K and leaving 5,856 shares worth $430K. The position accounts for 0.86% of the portfolio, ranked #45.

AtonRa Partners first reported a position in BRKR in Q3 2021 and has held it in 10 quarters since. The position peaked at $1.37M in Q4 2021. 360 funds tracked by Wall St. Rank hold BRKR as of Q4 2023.

  • AtonRa Partners held 5,856 shares of Bruker worth $430K as of Q4 2023.
  • AtonRa Partners sold 579 Bruker shares in Q4 2023, an estimated $37.1K.
  • Bruker made up 0.86% of AtonRa Partners's portfolio in Q4 2023, its #45 holding.
  • AtonRa Partners first reported a position in Bruker in Q3 2021 and has held it in 10 quarters since.
  • AtonRa Partners's Bruker position peaked at $1.37M in Q4 2021.
  • 360 funds tracked by Wall St. Rank held Bruker as of Q4 2023.

Based on AtonRa Partners's 13F filing for Q4 2023, filed 5 Feb 2024.